Lantus Novo Nordisk - Search News

News

Novo Nordisk Pops

Novo Nordisk Shares Fall After Data From New Eli Lilly Pill

The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s blockbuster shots.

Bloomberg · 2d

Novo Nordisk Slides on Pressure From Lilly’s Pill Study

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic.

Investor's Business Daily on MSN · 1d

Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill

Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Hosted on MSN27d

Senate panel questions Novo Nordisk CEO over decision to discontinue this popular insulin

Novo Nordisk's decision has been criticized by some patients with Type 1 diabetes who prefer Levemir over other long-acting "basal" insulins such as Sanofi's Lantus and Novo Nordisk's ...

pharmaphorum4d

Lilly and Boehringer biosimilar undercuts Lantus by 15%

The list price of Basaglar will be $316.85 for a pack of five pens, 15% below the list price of Lantus. The companies also hope to steal market share from Novo Nordisk, undercutting the long ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Novo Nordisk Pops

Trending now